QQQ   413.98 (-2.23%)
AAPL   165.02 (-1.21%)
MSFT   399.23 (-1.25%)
META   480.34 (-4.28%)
GOOGL   153.88 (-1.37%)
AMZN   174.01 (-2.91%)
TSLA   147.25 (-1.79%)
NVDA   769.64 (-9.10%)
AMD   145.73 (-6.03%)
NIO   3.81 (-4.75%)
BABA   69.14 (+0.38%)
T   16.50 (+1.04%)
F   12.10 (+0.33%)
MU   106.14 (-5.17%)
GE   148.20 (-3.10%)
CGC   7.98 (+1.92%)
DIS   112.19 (-0.21%)
AMC   3.18 (+8.90%)
PFE   25.99 (+2.36%)
PYPL   61.89 (-0.34%)
XOM   119.99 (+1.24%)
QQQ   413.98 (-2.23%)
AAPL   165.02 (-1.21%)
MSFT   399.23 (-1.25%)
META   480.34 (-4.28%)
GOOGL   153.88 (-1.37%)
AMZN   174.01 (-2.91%)
TSLA   147.25 (-1.79%)
NVDA   769.64 (-9.10%)
AMD   145.73 (-6.03%)
NIO   3.81 (-4.75%)
BABA   69.14 (+0.38%)
T   16.50 (+1.04%)
F   12.10 (+0.33%)
MU   106.14 (-5.17%)
GE   148.20 (-3.10%)
CGC   7.98 (+1.92%)
DIS   112.19 (-0.21%)
AMC   3.18 (+8.90%)
PFE   25.99 (+2.36%)
PYPL   61.89 (-0.34%)
XOM   119.99 (+1.24%)
QQQ   413.98 (-2.23%)
AAPL   165.02 (-1.21%)
MSFT   399.23 (-1.25%)
META   480.34 (-4.28%)
GOOGL   153.88 (-1.37%)
AMZN   174.01 (-2.91%)
TSLA   147.25 (-1.79%)
NVDA   769.64 (-9.10%)
AMD   145.73 (-6.03%)
NIO   3.81 (-4.75%)
BABA   69.14 (+0.38%)
T   16.50 (+1.04%)
F   12.10 (+0.33%)
MU   106.14 (-5.17%)
GE   148.20 (-3.10%)
CGC   7.98 (+1.92%)
DIS   112.19 (-0.21%)
AMC   3.18 (+8.90%)
PFE   25.99 (+2.36%)
PYPL   61.89 (-0.34%)
XOM   119.99 (+1.24%)
QQQ   413.98 (-2.23%)
AAPL   165.02 (-1.21%)
MSFT   399.23 (-1.25%)
META   480.34 (-4.28%)
GOOGL   153.88 (-1.37%)
AMZN   174.01 (-2.91%)
TSLA   147.25 (-1.79%)
NVDA   769.64 (-9.10%)
AMD   145.73 (-6.03%)
NIO   3.81 (-4.75%)
BABA   69.14 (+0.38%)
T   16.50 (+1.04%)
F   12.10 (+0.33%)
MU   106.14 (-5.17%)
GE   148.20 (-3.10%)
CGC   7.98 (+1.92%)
DIS   112.19 (-0.21%)
AMC   3.18 (+8.90%)
PFE   25.99 (+2.36%)
PYPL   61.89 (-0.34%)
XOM   119.99 (+1.24%)
Free Trial

Calliditas Therapeutics AB (publ) (CALT) News Today

→ Strange new buyer driving up gold (From Stansberry Research) (Ad)
Free CALT Stock Alerts
$17.68
+0.03 (+0.17%)
(As of 01:01 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media
SourceHeadline
marketbeat.com logoCalliditas Therapeutics AB (publ) (NASDAQ:CALT) Trading 3.4% Higher
marketbeat.com - April 19 at 12:24 PM
benzinga.com logoLatest News for Calliditas Therapeutics Stock (NASDAQ:CALT)
benzinga.com - April 19 at 9:04 AM
MarketBeat logoCalliditas Therapeutics AB (publ) (NASDAQ:CALT) Shares Gap Up to $17.80
americanbankingnews.com - April 19 at 5:36 AM
marketbeat.com logoCalliditas Therapeutics AB (publ) (NASDAQ:CALT) Shares Gap Down to $18.74
marketbeat.com - April 18 at 1:56 PM
prnewswire.com logoCalliditas Therapeutics Presents Additional Data Analyses from the Phase 3 NeflgArd trial of Nefecon in Primary IgA Nephropathy at the ISN World Congress of Nephrology 2024
prnewswire.com - April 18 at 7:10 AM
MarketBeat logoCalliditas Therapeutics AB (publ) (NASDAQ:CALT) Shares Gap Down to $21.52
americanbankingnews.com - April 13 at 5:42 AM
MarketBeat logoCalliditas Therapeutics AB (publ) (NASDAQ:CALT) Trading Down 8.3%
americanbankingnews.com - April 12 at 5:44 AM
markets.businessinsider.com logoBuy Rating Affirmed for Calliditas Therapeutics Amid Positive Market Trends and Upcoming Catalysts
markets.businessinsider.com - April 11 at 6:57 PM
marketbeat.com logoCalliditas Therapeutics AB (publ) (NASDAQ:CALT) Short Interest Down 56.2% in March
marketbeat.com - April 11 at 5:23 PM
marketbeat.com logoCalliditas Therapeutics AB (publ) (NASDAQ:CALT) Stock Price Down 8.3%
marketbeat.com - April 10 at 12:57 PM
finance.yahoo.com logoCalliditas Therapeutics to Attend Conferences in April
finance.yahoo.com - April 9 at 9:13 AM
prnewswire.com logoCalliditas Therapeutics to Attend Conferences in April
prnewswire.com - April 9 at 7:22 AM
markets.businessinsider.com logoCalliditas Gets Notice Of Allowance For U.S. Patent Application Covering Setanaxib To Treat Cancer
markets.businessinsider.com - April 8 at 10:32 AM
prnewswire.com logoCalliditas Therapeutics to Present Nefecon Data at the ISN World Congress of Nephrology April 13 - 16 in Buenos Aires
prnewswire.com - April 8 at 8:32 AM
prnewswire.com logoCalliditas receives notice of allowance for United States patent application covering setanaxib in cancer treatment
prnewswire.com - April 8 at 3:22 AM
cnn.com logoCalliditas Therapeutics AB Sponsored ADR
cnn.com - April 7 at 2:38 AM
marketbeat.com logoCalliditas Therapeutics AB (publ) (NASDAQ:CALT) Shares Gap Up to $21.25
marketbeat.com - April 4 at 1:20 PM
marketbeat.com logoCalliditas Therapeutics AB (publ) (NASDAQ:CALT) Shares Up 4.5%
marketbeat.com - April 1 at 3:29 PM
marketbeat.com logoCalliditas Therapeutics AB (publ) (NASDAQ:CALT) Sees Significant Growth in Short Interest
marketbeat.com - March 31 at 10:34 PM
marketbeat.com logoCalliditas Therapeutics AB (publ) (NASDAQ:CALT) Shares Gap Down to $21.49
marketbeat.com - March 28 at 7:27 PM
marketbeat.com logoCalliditas Therapeutics AB (publ) (NASDAQ:CALT) Stock Price Down 3.8%
marketbeat.com - March 26 at 5:46 PM
marketbeat.com logoCalliditas Therapeutics AB (publ) (NASDAQ:CALT) Shares Down 7.2%
marketbeat.com - March 19 at 4:49 PM
marketbeat.com logoCalliditas Therapeutics AB (publ) (NASDAQ:CALT) Shares Gap Down to $22.30
marketbeat.com - March 18 at 11:23 AM
marketbeat.com logoCalliditas Therapeutics AB (publ) (NASDAQ:CALT) Sees Large Increase in Short Interest
marketbeat.com - March 14 at 7:52 PM
prnewswire.com logoEverest Medicines' Partner Calliditas Therapeutics Announces U.S. FDA Grants an Additional Seven-Year Orphan Drug Exclusivity Period for Nefecon®
prnewswire.com - March 11 at 9:28 PM
finanznachrichten.de logoCalliditas Therapeutics: Calliditas announces an additional seven year orphan drug exclusivity period for TARPEYO
finanznachrichten.de - March 6 at 9:24 PM
finanznachrichten.de logoCalliditas Therapeutics: Calliditas announces an additional seven year orphan drug exclusivity period for TARPEYO®
finanznachrichten.de - March 6 at 4:23 PM
prnewswire.com logoCalliditas announces an additional seven year orphan drug exclusivity period for TARPEYO®
prnewswire.com - March 6 at 2:34 AM
prnewswire.com logoCalliditas Therapeutics to Attend Investor Conferences in March
prnewswire.com - March 1 at 7:39 AM
msn.com logoFulcrum Therapeutics Q4 2023 Earnings Preview
msn.com - February 26 at 12:56 PM
msn.com logoCalliditas Therapeutics AB (CALT) Price Target Increased by 5.27% to 42.86
msn.com - February 25 at 10:38 AM
finance.yahoo.com logoCalliditas Therapeutics AB (publ) (NASDAQ:CALT) Q4 2023 Earnings Call Transcript
finance.yahoo.com - February 22 at 12:53 PM
markets.businessinsider.com logoCalliditas Therapeutics: Strong Sales and FDA Approval Propel Buy Rating
markets.businessinsider.com - February 22 at 7:53 AM
marketbeat.com logoCalliditas Therapeutics AB (publ) (NASDAQ:CALT) Sees Strong Trading Volume
marketbeat.com - February 21 at 11:27 AM
prnewswire.com logoCalliditas Year-end report, January - December 2023
prnewswire.com - February 21 at 1:43 AM
finance.yahoo.com logoInvitation to the presentation of Calliditas´ Year-end report January - December 2023
finance.yahoo.com - February 14 at 3:49 AM
prnewswire.com logoInvitation to the presentation of Calliditas´ Year-end report January - December 2023
prnewswire.com - February 14 at 1:09 AM
msn.com logoAN2 Therapeutics extends losses as Leerink cuts on trial setback
msn.com - February 13 at 12:46 PM
finance.yahoo.com logoCalliditas provides patent update
finance.yahoo.com - February 13 at 12:46 PM
marketbeat.com logoCalliditas Therapeutics AB (publ) (NASDAQ:CALT) Trading Up 9.4%
marketbeat.com - February 6 at 4:30 PM
marketbeat.com logoCalliditas Therapeutics AB (publ) (NASDAQ:CALT) Short Interest Update
marketbeat.com - January 26 at 10:35 PM
marketbeat.com logoCalliditas Therapeutics AB (publ) (NASDAQ:CALT) Short Interest Up 20.0% in December
marketbeat.com - January 14 at 2:30 PM
finance.yahoo.com logoCalliditas Therapeutics provides business update ahead of JP Morgan conference
finance.yahoo.com - January 8 at 9:25 AM
finance.yahoo.com logoCalliditas to present at JP Morgan Healthcare Conference
finance.yahoo.com - January 7 at 1:30 PM
finance.yahoo.com logoCalliditas Therapeutics appoints Maria Törnsén as President North America
finance.yahoo.com - January 7 at 1:30 PM
marketbeat.com logoShort Interest in Calliditas Therapeutics AB (publ) (NASDAQ:CALT) Decreases By 29.2%
marketbeat.com - December 30 at 12:38 PM
msn.com logoCalliditas refinances existing term loan with EUR 92M senior secured facility
msn.com - December 27 at 2:27 PM
finance.yahoo.com logoCalliditas refinances existing term loan with Euro 92 million senior secured facility with Athyrium Capital
finance.yahoo.com - December 27 at 2:27 PM
markets.businessinsider.com logoBuy Rating for Calliditas Therapeutics Backed by FDA Approval and Strong Sales Growth Potential
markets.businessinsider.com - December 21 at 11:05 PM
msn.com logoBiggest stock movers today: Calliditas Therapeutics, BlackBerry
msn.com - December 21 at 8:03 AM
Get Calliditas Therapeutics AB (publ) News Delivered to You Automatically

Sign up to receive the latest news and ratings for CALT and its competitors with MarketBeat's FREE daily newsletter.

Strange new buyer driving up gold (Ad)

One Wall Street trader just made a big new gold prediction: "Pay attention to physical demand for gold... the interest seen over the last week has been unprecedented."

But there's a much better move you can make to get in front of these big moves today.

CALT Media Mentions By Week

CALT Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CALT
News Sentiment
▼
0.63

0.52
▲
Average
Medical
News Sentiment

CALT News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CALT Articles
This Week
▼
6

1
▲
CALT Articles
Average Week

Get Calliditas Therapeutics AB (publ) News Delivered to You Automatically

Sign up to receive the latest news and ratings for CALT and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:CALT) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The “Perfect Storm” for Gold
Gold Safe Exchange
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Biden’s $374B Giveaway Into This Sector
DTI
He Is Giving Away Bitcoin
Crypto Swap Profits
Your Money is Not Safe
American Alternative
The #1 Crypto for 2024
InvestorPlace
SHOCKING Crypto Leak…
Crypto 101 Media
My biggest AI fear
Paradigm Press